ADVERSE EFFECTS In the cagrilintide, single-agent study between 2% and 6% (26%) of participants in the cagrilintide groups discontinued treatment prematurely because of adverse events, compared with 7% (7%) of participants in the liraglutide 3.0 mg group and 3% (3%) in the pooled placebo group
GLP-1 and GIP receptors are expressed in regions including the hypothalamus, hindbrain, and area postrema, and tirzepatide is used as a tool compound to probe how dual receptor engagement modulates neuronal firing, appetite-related gene expression, and neuroinflammation markers in cell and organoid systems
Bioavailability data in humans is scarce, though animal studies suggest oral dosing retains gastrointestinal healing effects 4
For many people, they represent a genuine medical advance one supported by robust clinical trials and meaningful improvements in metabolic health
The Role of Semaglutide in Type 2 Diabetes This has led some to seek new alternatives, like semaglutide, which has recently emerged as a promising option